1.
Troch M, Jonak C, Müllauer L, Püspök A, Formanek M, Hauff W, Zielinski CC, Chott A, Raderer M. A phase II study of bortezomib in patients with MALT lymphoma. Haematologica [Internet]. 2009Apr.30 [cited 2026Oct.29];94(5):738-42. Available from: https://haematologica.org/article/view/5255